CLINICAL_TRIALS
trial_result
· 2009-06-23
Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder [Phase 3]
Summary
A Phase 3 efficacy and safety study of Seroquel SR for generalized anxiety disorder has completed. Results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED | Results posted: 2009-06-23